Drug Infusion System Market Size & Share Analysis - Growth Trends And Forecast (2025 - 2032)

By Product Type;

Elastomeric Infusion System, Disposable Infusion System, Syringe Infusion System, Peristaltic Pump, Multi-Channel Pump, Patient-Controlled Analgesia (PCA) Pump, Insulin Pump and Implantable Infusion System

By Application;

Oncology & Chemotherapy, Diabetes, Analgesia, Nutrition, Hematology, Pediatrics and Others

By Mode of Administration;

Intravenous, Subcutaneous, Arterial, Epidural and Others

By End User;

Hospitals, Ambulatory Surgical Centers, Diagnostic Centers and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2022 - 2032)
Report ID: Rn563031696 Published Date: April, 2026 Updated Date: May, 2026

Drug Infusion System Market Overview

Drug Infusion System Market (USD Million)

Drug Infusion System Market was valued at USD 16,368.31 million in the year 2025. The size of this market is expected to increase to USD 26,456.37 million by the year 2032, while growing at a Compounded Annual Growth Rate (CAGR) of 7.1%.


Drug Infusion System Market

*Market size in USD million

CAGR 7.1 %


Study Period2026 - 2032
Base Year2025
CAGR (%)7.1 %
Market Size (2025)USD 16,368.31 Million
Market Size (2032)USD 26,456.37 Million
Market ConcentrationMedium
Report Pages388
16,368.31
2025
26,456.37
2032

Major Players

  • Becton Dickinson and Company BD
  • B Braun Melsungen AG
  • Baxter International Inc
  • ICU Medical Inc
  • Fresenius SE and Co KGaA
  • Medtronic Inc
  • Terumo Corporation
  • CareFusion now part of BD
  • Polymedicure
  • Option Care Health Inc
*Competitors List Not Exhaustive

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Drug Infusion System Market

Fragmented - Highly competitive market without dominant players


Drug Infusion System Market is expanding rapidly, with more than 60% of healthcare providers implementing advanced infusion devices for reliable and precise drug administration. These systems support consistent dosing and reduce the likelihood of errors, aligning with broader growth strategies focused on improving patient outcomes. Their increased use reflects an industry-wide move toward safety, consistency, and reliable long-term delivery models.

Intelligent Features Enhancing Delivery Precision
Approximately 35% of newer infusion technologies include smart displays, error alerts, and real-time infusion monitoring, providing clinicians with better visibility and control. These innovations support more effective therapies by preventing interruptions and increasing dosing precision. As the industry continues to advance, these tools are laying the foundation for a more connected and technologically advanced future in infusion management.

Regulation and Training Driving Market Acceptance
Over 50% of healthcare systems rely on certified infusion platforms that comply with safety guidelines and offer structured training to clinical staff. These safety-oriented features increase clinician trust and improve the reliability of care delivery. As compliance remains central to system selection, the market continues to see expansion supported by well-defined strategies that prioritize patient protection.

Personalized Delivery Systems Shaping the Future
Close to 45% of new R&D spending is focused on digital infusion systems that adapt drug delivery in real time based on patient data and monitoring trends. These platforms allow for more responsive care and remote treatment supervision. With smart dosing tools becoming more prevalent, the market is progressing toward a future outlook defined by intelligent, connected drug administration solutions and continuous growth potential.

Drug Infusion System Market Key Takeaways

  • The increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular conditions is driving the demand for drug infusion systems to provide continuous medication delivery.

  • Technological advancements in smart infusion pumps are improving accuracy and patient safety by integrating features like dose tracking, remote monitoring, and alarm systems to prevent medication errors.

  • The rise in home healthcare services is pushing the demand for portable drug infusion systems, enabling patients to receive continuous care at home, which reduces hospital admissions and healthcare costs.

  • As healthcare becomes more personalized, there is increasing interest in customized infusion systems designed to deliver patient-specific drug regimens, optimizing therapeutic outcomes.

  • The shift toward patient-centric care is encouraging the development of infusion systems that offer user-friendly interfaces, increased mobility, and minimal invasiveness to improve overall patient comfort and experience.

  • The integration of data analytics in infusion pumps is enabling healthcare providers to monitor and adjust medication delivery in real-time, leading to improved treatment plans and patient outcomes.

  • Regulatory requirements and standards for drug safety and device performance are pushing manufacturers to innovate, ensuring that infusion systems meet the highest quality and safety standards to prevent adverse events.

Drug Infusion System Market Recent Developments

  • On September 24, 2024, Linear Health Sciences received expanded FDA approval for its Orchid Safety Release Valve (SRV), allowing use in patients aged two weeks and older. The approval enhances treatment efficiency and improves patient safety by reducing the risk of IV line dislodgement during medical procedures.

  • In September 2020, B. Braun Melsungen obtained FDA 510(k) clearance for its SpaceStation MRI, enabling the use of Space® infusion pumps to safely deliver medications within MRI environments. This advancement improves treatment continuity and enhances patient care efficiency during diagnostic imaging procedures.

Drug Infusion System Market Segment Analysis

Drug Infusion System Market has been segmented by Product, Application, Mode of Administration, End-User and Geography.

Drug Infusion System Market, Segmentation by Product

Drug Infusion System Market has been segmented by Product into Elastomeric Infusion System, Disposable Infusion System, Syringe Infusion System, Peristaltic Pump, Multi-Channel Pump, Patient-Controlled Analgesia (PCA) Pump, Insulin Pump and Implantable Infusion System.

Elastomeric Infusion System

The elastomeric infusion system is widely recognized for its portability and ease of use, making it a preferred choice in home healthcare and ambulatory care. Operating without electricity, it reduces both complexity and cost. This segment accounts for nearly 25% of the global market, with strong adoption in chemotherapy and antibiotic delivery.

Disposable Infusion System

The disposable infusion system is designed for single-use applications to reduce the risk of cross-contamination and improve patient safety. With stricter infection-control protocols in healthcare facilities, this segment captures about 18% of the market, largely driven by demand from hospitals and outpatient centers.

Syringe Infusion System

The syringe infusion system delivers accurate small-volume medication dosing, making it essential for pediatric and neonatal care. Its compact design and easy programming capabilities have contributed to its approximately 15% share of the market.

Peristaltic Pump

The peristaltic pump offers high accuracy with minimal contamination risk since the drug only contacts the tubing. Representing nearly 12% of the market, it is widely utilized in oncology, pain management, and nutritional therapy.

Multi-Channel Pump

The multi-channel pump enables the simultaneous delivery of multiple medications, enhancing treatment efficiency for patients with complex therapeutic needs. This segment holds close to 10% of the market, with significant adoption in intensive care units and advanced hospital settings.

Patient-Controlled Analgesia (PCA) Pump

The PCA pump empowers patients to self-administer controlled doses of pain medication, improving comfort and recovery outcomes. Accounting for around 8% of the market, it is increasingly used in post-surgical care and chronic pain management.

Insulin Pump

The insulin pump market is growing rapidly due to the rising incidence of diabetes worldwide. These devices allow for continuous and adjustable insulin delivery, contributing about 7% to the overall drug infusion system market.

Implantable Infusion System

The implantable infusion system offers long-term, targeted delivery for patients with chronic conditions such as cancer pain and spasticity. Although niche, it accounts for approximately 5% of the market, valued for its ability to provide uninterrupted therapy over extended periods.

Drug Infusion System Market, Segmentation by Application

The Drug Infusion System Market has been segmented by Application into Oncology/Chemotherapy, Diabetes, Analgesia, Nutrition, Hematology, Pediatrics and Others.

Oncology/Chemotherapy

The oncology/chemotherapy segment represents the largest share of the drug infusion system market, accounting for nearly 35%. These systems are crucial for delivering precise doses of anti-cancer drugs over extended periods, improving patient outcomes and minimizing side effects. Growing cancer prevalence worldwide is a major driver of demand in this category.

Diabetes

The diabetes segment accounts for approximately 20% of the market, fueled by the rising global burden of the disease. Infusion systems, particularly insulin pumps, offer continuous and adjustable insulin delivery, helping maintain stable blood glucose levels and reducing the risk of long-term complications.

Analgesia

The analgesia segment holds close to 15% of the market, with infusion pumps widely used for postoperative pain management and chronic pain therapy. Patient-controlled analgesia systems enable tailored pain relief, enhancing comfort and recovery times.

Nutrition

The nutrition segment contributes around 10% to the market, primarily driven by patients requiring parenteral nutrition due to gastrointestinal disorders or surgery. Drug infusion systems ensure accurate delivery of essential nutrients over extended periods, supporting better patient health outcomes.

Hematology

The hematology segment accounts for nearly 8% of the market. Infusion systems are used in treatments such as blood transfusions, iron infusions, and other hematologic therapies, offering precise dosing and reduced risk of adverse events.

Pediatrics

The pediatrics segment represents about 7% of the market, focusing on accurate and safe drug delivery for infants and children. Infusion systems in this category are specially designed to handle small-volume dosing required in neonatal and pediatric care.

Others

The others segment makes up nearly 5% of the market, encompassing varied applications such as hormone therapy, antibiotic delivery, and palliative care. This category is expected to grow steadily with the diversification of infusion-based treatments.

Drug Infusion System Market, Segmentation by Mode of Administration

Drug Infusion System Market has been segmented by Mode Of Administration into Intravenous, Subcutaneous, Arterial, Epidural and Others.

Intravenous

The intravenous mode of administration dominates the drug infusion system market, accounting for nearly 45% of total usage. It enables rapid and controlled delivery of medications, fluids, and nutrients directly into the bloodstream, making it essential for critical care, oncology, and emergency medicine.

Subcutaneous

The subcutaneous segment holds approximately 20% of the market, widely used for therapies requiring slow, sustained absorption such as insulin delivery and hormone treatments. It offers patients greater comfort and convenience, particularly for long-term care.

Arterial

The arterial route accounts for about 12% of the market and is primarily utilized in specialized treatments such as intra-arterial chemotherapy and targeted drug delivery. It allows for high concentrations of medication to reach specific organs or tissues.

Epidural

The epidural mode represents nearly 10% of the market, with common applications in pain management during childbirth and postoperative recovery. It provides localized pain relief while minimizing systemic drug exposure.

Others

The others category makes up close to 13% of the market, encompassing less common administration routes such as intraperitoneal, intramuscular, and intraocular delivery. These methods are chosen for specific clinical needs where conventional routes are less effective.

Drug Infusion System Market, Segmentation by End-User

The Drug Infusion System Market has been segmented by End-User into Hospitals, Ambulatory Surgical Centers, Diagnostic Centers and Others.

Hospitals

The hospitals segment holds the largest share of the drug infusion system market, accounting for nearly 50%. Hospitals require these systems for a wide range of treatments including chemotherapy, pain management, and critical care, benefiting from their ability to deliver precise and controlled drug dosages.

Ambulatory Surgical Centers

The ambulatory surgical centers segment represents about 20% of the market. These centers use infusion systems extensively for day surgeries and postoperative recovery, offering efficient, cost-effective patient care with shorter hospital stays.

Diagnostic Centers

The diagnostic centers segment accounts for approximately 15% of the market, where infusion systems are often used for administering contrast agents in imaging procedures and delivering drugs for specialized diagnostic tests.

Others

The others category contributes around 15% of the market, including applications in home healthcare, rehabilitation centers, and other outpatient settings. Growth in this segment is driven by increasing adoption of portable and user-friendly infusion devices.

Drug Infusion System Market, Segmentation by Geography

Drug Infusion System Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Regions and Countries Analyzed in this Report

Legend
North America
Rest of North America
Europe
Rest of Europe
Asia Pacific
Rest of Asia Pacific
Middle East and Africa
Rest of Middle East and Africa
Latin America
Rest of Latin America
Rest of the World

North America

North America dominates drug infusion system market with an estimated share of nearly 40%. The region benefits from advanced healthcare infrastructure, high adoption of innovative medical devices, and a significant patient base requiring chronic disease management, particularly in oncology and diabetes care.

Europe

Europe accounts for approximately 25% of the market, supported by strong government healthcare initiatives and widespread adoption of infusion systems in hospitals and specialty clinics. The presence of leading medical device manufacturers further strengthens market growth in this region.

Asia Pacific

Asia Pacific holds around 20% of the market and is expected to witness the fastest growth due to rising healthcare investments, expanding hospital networks, and increasing prevalence of chronic diseases. Countries like China, India, and Japan are key growth contributors.

Middle East and Africa

The Middle East and Africa region represents nearly 8% of the market, driven by improving healthcare infrastructure and growing demand for advanced medical devices. Adoption is gradually increasing in both urban hospitals and specialized care centers.

Latin America

Latin America holds close to 7% of the market, supported by increasing access to modern healthcare facilities and a rising number of public-private partnerships in the medical sector. Brazil and Mexico are the leading markets in this region.

Drug Infusion System Market Forces

This report provides an in depth analysis of various factors that impact the dynamics of Drug Infusion System Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Comprehensive Market Impact Matrix

This matrix outlines how core market forces Drivers, Restraints, and Opportunities affect key business dimensions including Growth, Competition, Customer Behavior, Regulation, and Innovation.

Market Forces ↓ / Impact Areas → Market Growth Rate Competitive Landscape Customer Behavior Regulatory Influence Innovation Potential
High impact (e.g., tech adoption, rising demand) Encourages new entrants and fosters expansion Increases usage and enhances demand elasticity Often aligns with progressive policy trends Fuels R&D initiatives and product development
Restraints Slows growth (e.g., high costs, supply chain issues) Raises entry barriers and may drive market consolidation Deters consumption due to friction or low awareness Introduces compliance hurdles and regulatory risks Limits innovation appetite and risk tolerance
Opportunities Unlocks new segments or untapped geographies Creates white space for innovation and M&A Opens new use cases and shifts consumer preferences Policy shifts may offer strategic advantages Sparks disruptive innovation and strategic alliances

Drivers, Restraints and Opportunity Analysis

Drivers

  • Technological Advancements in Infusion Systems
  • Rising Prevalence of Chronic Diseases
  • Increasing Demand for Home Infusion Therapy

  • Growing Geriatric Population: The growing geriatric population is a significant driver shaping the Drug Infusion System Market. As the population ages, there is a concurrent increase in the prevalence of chronic diseases and conditions that require long-term management, such as diabetes, cardiovascular diseases, and cancer. Geriatric patients often have complex medical needs and may require multiple medications delivered through infusion therapy to manage their health effectively. Drug infusion systems offer a convenient and efficient means of delivering medications, fluids, and nutrients to elderly patients, ensuring precise dosing, continuous monitoring, and improved treatment adherence. Moreover, as older adults may have reduced mobility and may be unable to self-administer medications orally, infusion therapy provides a viable alternative for delivering medications directly into the bloodstream or targeted anatomical sites, enhancing patient comfort and quality of life.

    The aging population is driving the demand for specialized healthcare services, including infusion therapy, both in acute care settings and in-home environments. Hospitals, ambulatory care centers, and home healthcare agencies are adapting to meet the unique needs of geriatric patients by investing in advanced drug infusion systems and expanding their infusion therapy programs. Additionally, the geriatric population often presents with comorbidities and age-related physiological changes that require tailored treatment approaches, such as individualized medication regimens and customized infusion protocols. As a result, manufacturers are focusing on developing infusion pumps and devices with user-friendly interfaces, safety features, and remote monitoring capabilities to meet the specific needs of elderly patients and healthcare providers. Overall, the growing geriatric population is driving increased demand for drug infusion systems, fueling market growth and innovation in the healthcare industry.

Restraints

  • Limited Reimbursement Coverage for Infusion Therapy
  • Stringent Regulatory Requirements for Device Approval
  • Risk of Medication Errors and Device Malfunctions

  • Challenges in Standardizing Infusion Protocols: Standardizing infusion protocols poses a significant challenge in the Drug Infusion System Market due to the diverse range of medications, dosing regimens, and patient populations encountered in clinical practice. Healthcare providers often face inconsistencies and variations in infusion protocols across different healthcare facilities, departments, and geographical regions, leading to potential errors, inefficiencies, and compromised patient safety. Standardization efforts are hindered by the lack of uniform guidelines, protocols, and best practices for infusion therapy, resulting in confusion, miscommunication, and suboptimal treatment outcomes. Additionally, the complexity of infusion therapy, including factors such as drug compatibility, infusion rates, and patient-specific considerations, further complicates the standardization process, as healthcare providers must navigate multiple variables to ensure safe and effective medication delivery.

    The rapid evolution of medical technologies and infusion system platforms adds to the challenge of standardizing infusion protocols, as healthcare facilities may struggle to keep pace with emerging trends and updates in device functionalities. Integrating new infusion pumps, software upgrades, and connectivity features into existing clinical workflows requires extensive training, coordination, and resources, posing logistical and financial challenges for healthcare organizations. Furthermore, interoperability issues between infusion devices, electronic health records (EHR) systems, and medication management platforms hinder seamless data exchange and communication, impeding efforts to standardize infusion protocols and achieve quality improvement initiatives. Despite these challenges, stakeholders in the Drug Infusion System Market are actively collaborating with healthcare organizations, regulatory agencies, and standard-setting bodies to develop consensus guidelines, promote best practices, and address barriers to standardization, ultimately enhancing patient safety, clinical efficiency, and healthcare quality.

Opportunities

  • Expansion of Home Healthcare Services
  • Increasing Adoption of Ambulatory Care Models
  • Technological Innovations in Infusion Pump Design

  • Growth of Precision Medicine and Personalized Therapy: The growth of precision medicine and personalized therapy is significantly influencing the Drug Infusion System Market by driving demand for tailored drug delivery solutions that align with individual patient needs and treatment requirements. Precision medicine emphasizes the customization of healthcare interventions based on patients' genetic makeup, biomarkers, and clinical characteristics, aiming to optimize treatment outcomes and minimize adverse effects. Drug infusion systems play a pivotal role in delivering personalized therapies by enabling precise dosing, targeted drug delivery, and individualized treatment regimens. For instance, infusion pumps equipped with programmable settings and dosage algorithms allow healthcare providers to administer medications at optimal rates and intervals, ensuring therapeutic efficacy while minimizing the risk of toxicity or underdosing. Additionally, advancements in infusion pump technologies, such as smart pumps with integrated sensors and connectivity features, facilitate real-time monitoring of patients' physiological parameters and drug responses, enabling healthcare providers to adjust therapy regimens and optimize patient care based on personalized data insights.

    Personalized therapy approaches, such as immunotherapy and cell-based therapies, are driving the demand for specialized drug infusion systems capable of delivering biologic agents, gene therapies, and cell-based products with precision and accuracy. Infusion pumps and devices are utilized in administering these cutting-edge therapies, ensuring controlled delivery and minimizing the risk of immunogenicity, cytokine release syndrome, and other adverse reactions. Moreover, the integration of infusion systems with companion diagnostics, pharmacogenomics, and digital health platforms enables healthcare providers to tailor infusion therapy protocols based on patients' genetic profiles, pharmacokinetics, and treatment responses, enhancing therapeutic outcomes and patient satisfaction. As precision medicine continues to revolutionize healthcare delivery, the Drug Infusion System Market is poised to expand further, offering innovative solutions that support personalized treatment approaches and improve patient care across diverse therapeutic areas and clinical settings.

Drug Infusion System Market Competitive Landscape Analysis

Drug Infusion System Market presents a dynamic competitive landscape defined by strong strategies, cross-industry partnerships, and frequent merger activities. Leading players emphasize innovation and growth in response to rising healthcare demands, focusing on integrated delivery models and technology-enabled infusion devices to enhance patient safety and treatment accuracy.

Market Structure and Concentration

The market shows a balanced mix of established leaders and emerging innovators, with several companies capturing over significant percentages of market share. Increasing collaboration between device manufacturers and software providers strengthens technological advancements, while strategies for diversified portfolios and regional presence ensure a resilient competitive edge.

Brand and Channel Strategies

Prominent firms adopt multi-tier brand positioning and integrated channel approaches to reach hospitals, specialty clinics, and homecare settings. This includes partnerships with distributors, targeted marketing strategies, and investment in training to ensure device compliance and seamless integration into healthcare workflows, reinforcing trust and market reach.

Innovation Drivers and Technological Advancements

Continuous innovation in smart infusion pumps, wireless monitoring, and AI-based dosing algorithms drives the market forward. Companies are implementing technological advancements through joint R&D, collaboration with academic institutes, and scaling new strategies to improve accuracy, safety, and interoperability of drug infusion systems across multiple care environments.

Regional Momentum and Expansion

Manufacturers are pursuing active expansion into emerging healthcare markets, leveraging regional partnerships and government-led initiatives to enhance infrastructure. High adoption percentages in developed regions and rapid growth in developing areas reflect how localized strategies drive competitive positioning and support long-term market penetration.

Future Outlook

The future outlook for drug infusion systems emphasizes sustained innovation, strong merger pipelines, and heightened collaboration across digital health ecosystems. With rising emphasis on patient-centric care and integrated platforms, companies aligning strategies with these trends are poised to secure higher percentages of market influence and maintain leadership in the evolving landscape.

Key players in Drug Infusion System Market include:

  • Becton, Dickinson & Company (BD)
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • ICU Medical, Inc.
  • Fresenius SE & Co. KGaA
  • Medtronic, Inc.
  • Terumo Corporation
  • CareFusion (now part of BD)
  • Polymedicure
  • Option Care Health, Inc.
  • CVS
  • Hospira
  • Contec Medical Systems Co., Ltd.
  • Smiths Medical
  • Teleflex

In this report, the profile of each market player provides following information:

  • Market Share Analysis
  • Company Overview and Product Portfolio
  • Key Developments
  • Financial Overview
  • Strategies
  • Company SWOT Analysis
  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By Application
    3. Market Snapshot, By Mode of Administration
    4. Market Snapshot, By End User
    5. Market Snapshot, By Region
  4. Drug Infusion System Market Forces
    1. Drivers, Restraints and Opportunities
      1. Drivers

        1. Technological Advancements in Infusion Systems

        2. Rising Prevalence of Chronic Diseases

        3. Increasing Demand for Home Infusion Therapy

        4. Growing Geriatric Population

      2. Restraints

        1. Limited Reimbursement Coverage for Infusion Therapy

        2. Stringent Regulatory Requirements for Device Approval

        3. Risk of Medication Errors and Device Malfunctions

        4. Challenges in Standardizing Infusion Protocols

      3. Opportunities

        1. Expansion of Home Healthcare Services

        2. Increasing Adoption of Ambulatory Care Models

        3. Technological Innovations in Infusion Pump Design

        4. Growth of Precision Medicine and Personalized Therapy

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Drug Infusion System Market, By Product Type, 2022 - 2032 (USD Million)
      1. Elastomeric Infusion System
      2. Disposable Infusion System
      3. Syringe Infusion System
      4. Peristaltic Pump
      5. Multi-Channel Pump
      6. Patient-Controlled Analgesia (PCA) Pump
      7. Insulin Pump
      8. Implantable Infusion System
    2. Drug Infusion System Market, By Application, 2022 - 2032 (USD Million)
      1. Oncology & Chemotherapy
      2. Diabetes
      3. Analgesia
      4. Nutrition
      5. Hematology
      6. Pediatrics
      7. Others
    3. Drug Infusion System Market, By Mode of Administration, 2022 - 2032 (USD Million)
      1. Intravenous
      2. Subcutaneous
      3. Arterial
      4. Epidural
      5. Others
    4. Drug Infusion System Market, By End User, 2022 - 2032 (USD Million)
      1. Hospitals
      2. Ambulatory Surgical Centers
      3. Diagnostic Centers
      4. Others
    5. Drug Infusion System Market, By Geography, 2022 - 2032 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Becton, Dickinson & Company (BD)
      2. B. Braun Melsungen AG
      3. Baxter International Inc.
      4. ICU Medical, Inc.
      5. Fresenius SE & Co. KGaA
      6. Medtronic, Inc.
      7. Terumo Corporation
      8. CareFusion
      9. Polymedicure
      10. Option Care Health, Inc.
      11. CVS
      12. Hospira
      13. Contec Medical Systems Co., Ltd.
      14. Smiths Medical
      15. Teleflex
  7. Analyst Views
  8. Future Outlook of the Market